Immunity to and frequency of reinfection with respiratory syncytial virus
- PMID: 2010624
- DOI: 10.1093/infdis/163.4.693
Immunity to and frequency of reinfection with respiratory syncytial virus
Abstract
To better understand the duration of immunity against respiratory syncytial virus (RSV) and the role of serum antibodies to the surface glycoproteins, F and G, in susceptibility to reinfection, 15 adults with previous natural RSV infection were challenged with RSV of the same strain group (A) at 2, 4, 8, 14, 20, and 26 months after natural infection. By 2 months about one-half and by 8 months two-thirds of the subjects became reinfected. Each challenge resulted in infection in at least one-fourth of the subjects. Within 26 months 73% had two or more and 47% had three or more infections. The duration of immunity tended to increase after two closely spaced infections. Higher neutralizing, F and GA antibody levels before challenge correlated significantly with protection against infection. However, even in subjects with the highest antibody levels, the risk of reinfection was 25%. Specific nasal IgA antibody titers did not correlate significantly with protection. This suggests that humoral neutralizing, F, and G antibodies correlate with resistance to reinfection, but protection is far from complete and is of short duration.
Similar articles
-
Humoral and mucosal immunity in protection from natural respiratory syncytial virus infection in adults.J Infect Dis. 2004 Jul 15;190(2):373-8. doi: 10.1086/421524. Epub 2004 Jun 18. J Infect Dis. 2004. PMID: 15216475
-
Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection.J Clin Microbiol. 1986 Jun;23(6):1009-14. doi: 10.1128/jcm.23.6.1009-1014.1986. J Clin Microbiol. 1986. PMID: 3754878 Free PMC article.
-
The immunologic response to infection with respiratory syncytial virus in infants.J Infect Dis. 1978 Jul;138(1):24-32. doi: 10.1093/infdis/138.1.24. J Infect Dis. 1978. PMID: 355574
-
[Effect of the humoral immune response on the pathogenesis of respiratory syncytial virus (RSV) infection].Immun Infekt. 1993 Jun;21(3):75-7. Immun Infekt. 1993. PMID: 8335338 Review. German.
-
Immunity to human and bovine respiratory syncytial virus.Arch Virol. 1990;112(1-2):1-25. doi: 10.1007/BF01348982. Arch Virol. 1990. PMID: 2196033 Review.
Cited by
-
Neonatal antibody responses are attenuated by interferon-γ produced by NK and T cells during RSV infection.Proc Natl Acad Sci U S A. 2013 Apr 2;110(14):5576-81. doi: 10.1073/pnas.1214247110. Epub 2013 Mar 18. Proc Natl Acad Sci U S A. 2013. PMID: 23509276 Free PMC article.
-
Human CD8(+) T Cells Target Multiple Epitopes in Respiratory Syncytial Virus Polymerase.Viral Immunol. 2016 Jun;29(5):307-14. doi: 10.1089/vim.2015.0091. Epub 2016 Apr 12. Viral Immunol. 2016. PMID: 27070377 Free PMC article.
-
Viral acute lower respiratory infections impair CD8+ T cells through PD-1.J Clin Invest. 2012 Aug;122(8):2967-82. doi: 10.1172/JCI62860. Epub 2012 Jul 17. J Clin Invest. 2012. PMID: 22797302 Free PMC article.
-
RSV-Induced H3K4 Demethylase KDM5B Leads to Regulation of Dendritic Cell-Derived Innate Cytokines and Exacerbates Pathogenesis In Vivo.PLoS Pathog. 2015 Jun 17;11(6):e1004978. doi: 10.1371/journal.ppat.1004978. eCollection 2015 Jun. PLoS Pathog. 2015. PMID: 26083387 Free PMC article.
-
Need for a safe vaccine against respiratory syncytial virus infection.Korean J Pediatr. 2012 Sep;55(9):309-15. doi: 10.3345/kjp.2012.55.9.309. Epub 2012 Sep 14. Korean J Pediatr. 2012. PMID: 23049587 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous